The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

Dr. Su Ryon Shin, Assistant Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School, gives a Chemical Engineering seminar titled, "Engineering nano-biomaterials for regenerative ...

CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment GUILDFORD, UNITED KINGDOM / ACCESSWIRE / November 15, 2024 / ...

Kala Pharmaceuticals ( (KALA) ) has released its Q3 earnings. Here is a breakdown of the information Kala Pharmaceuticals presented to its ...

The facility will offer families a unique opportunity to preserve their newborns’ stem cells in Qatar for potential future ...

The dissolvable microcarrier is produced using IamFluidics’ patented IN-AIR MICROFLUIDICS technology. It consists of alginate ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

间充质干细胞（Mesenchymal stem cell，MSC）是一种具有非凡潜力的多能干细胞。 从来源上看，MSC 可以从多种组织中获取，如骨髓、脂肪组织、脐带血、胎盘等。骨髓来源的 MSC 是最早被发现和研究的，它们在骨髓中犹如 ...

amniotic tissue, and ready to use mesenchymal stem cells (MSCs). The joint service is available for any family in the country ...